Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Multicentre, Open, Randomised, Parallel Group, Dose Ranging Study to Define the Efficacy of Dysport® in the Treatment of Anal Fissure.

NCT00210444 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00210444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Multicentre, Open, Randomised, Parallel Group, Dose Ranging Study to Define the Efficacy of Dysport® in the Treatment of Anal Fissure.
Lead sponsor
Ipsen
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
December 31, 2006
Enrollment
168 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

anal fissure